Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARγ mRNA expression and modulates SR-BI gene expression in murine macrophages

Molecular and Cellular Biochemistry

Volumn 277, Issue 1-2, 2005, Pages 143-152

  Westendorf, Thomas ^a   Graessler, Juergen ^a   Kopprasch, Steffi ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

CD36; Hypochlorite; Macrophage; Oxidized LDL; Scavenger receptor; SR BI

Indexed keywords

CD36 ANTIGEN; HYPOCHLORITE; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SCAVENGER RECEPTOR BI;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPOSURE; FEEDBACK SYSTEM; GENE EXPRESSION; HUMAN; MACROPHAGE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; ANTIGENS, CD36; BASE SEQUENCE; CELL LINE; CHEMOKINE CCL2; DNA; HYPOCHLOROUS ACID; LIPOPROTEINS, LDL; MACROPHAGES; MICE; PPAR GAMMA; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

MURINAE;

EID: 24144457806     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-5873-z     Document Type: Article

References (34)

1. Hazen SL, Heinecke JW: 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 99: 2075-2081, 1997 9151778
2. Thukkani AK, McHowat J, Hsu FF, Brennan ML, Hazen SL, Ford DA: Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 108: 3128-3133, 2003 10.1161/ 01.CIR.0000104564.01539.6A
3. 2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem 267: 4495-503, 2000 10.1046/j.1432-1327.2000.01498.x
4. Hazell LJ, Stocker R: Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 290: 165-172, 1993 8439285
5. Kopprasch S, Leonhardt W, Pietzsch J, Kühne H: Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells. Atherosclerosis 136: 315-324, 1998. 10.1016/S0021-9150(97)00233-5
6. Kopprasch S, Pietzsch J, Westendorf T, Kruse HJ, Graessler J: The pivotal role of scavenger receptor CD36 and phagocyte-derived oxidants in oxidized low density lipoprotein-induced adhesion to endothelial cells. Int J Biochem Cell Biol 36: 460-471, 2004 10.1016/ j.biocel.2003.08.001
7. Krieger M: Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest 108: 793-797, 2001 10.1172/JCI200114011
8. Nicholson AC, Frieda S, Pearce A, Silverstein RL: Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol 15: 269-75, 1995 7538425
9. Marsche G, Zimmermann R, Horiuchi S, Tandon NN, Sattler W, Malle E: Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein. J Biol Chem 278: 47562-47570, 2003 10.1074/jbc.M308428200
10. Feng J, Han J, Pearce SF, Silverstein RL, Gotto AM Jr, Hajjar DP, Nicholson AC: Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res 41: 688-696, 2000 10787429
11. Kavanagh IC, Symes CE, Renaudin P, Nova E, Mesa MD, Boukouvalas G, Leake DS, Yaqoob P: Degree of oxidation of low density lipoprotein affects expression of CD36 and PPARgamma, but not cytokine production, by human monocyte-macrophages. Atherosclerosis 168: 271-282, 2003 10.1016/ S0021-9150(03)00148-5
12. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93: 229-240, 1998 10.1016/S0092-8674(00)81574-3
13. Jiang C, Ting AT, Seed B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86, 1998 10.1038/35154
14. Chinetti G, Gbaguidi FG, Griglio S, Mallat Z, Antonucci M, Poulain P, Chapman J, Fruchart JC, Tedgui A, Najib-Fruchart J, Staels B: CLA-1/ SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101: 2411-2417, 2000 10821819
15. Pietzsch J, Subat S, Nitzsche S, Leonhardt W, Schentke KU, Hanefeld M: Very fast ultracentrifugation of serum lipoproteins: Influence on lipoprotein separation and composition. Biochim Biophys Acta 1254: 77-88, 1995 7811751
16. Shoji T, Nishizawa Y, Fukumoto M, Shimamura K, Kimura J, Kanda H, Emoto M, Kawagishi T, Morii H: Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 148: 171-177, 2000 0.1016/ S0021-9150(99)00218-X
17. Hazell LJ, Arnold L, Flowers, D, Waeg G, Malle E, Stocker R: Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 97: 1535-1544, 1996 8617887
18. Savill J, Hogg N, Haslett C: Macrophage vitronectin receptor, CD36, and thrombospondin cooperate in recognition of neutrophils undergoing programme cell death. Chest 99: 6S-7S, 1991
19. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA: Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268: 17665-17668, 1993 7688729
20. Aebbraio M, Hajjar DP, Silverstein RL: CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108: 785-791, 2001 10.1172/JCI200114006
21. Hirano K, Yamashita S, Nakagawa Y, Ohya T, Matsuura F, Tsukamoto K, Okamoto Y, Matsuyama A, Matsumoto K, Miyagawa J, Matsuzawa Y: Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ Res 85: 108-116, 1999 10400916
22. Rhainds D, Brissette L: The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. Defining the rules for lipid traders. Int J Biochem Cell Biol 36: 39-77, 2004 10.1016/S1357-2725(03)00173-0
23. Van Eck M, Bos IS, Hildebrand RB, Van Rij BT, Van Berkel TJC: Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am J Pathol 165: 785-794, 2004 15331403
24. Han J, Nicholson AC, Zhou X, Feng J, Gotto AM Jr, Hajjar DP: Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I. J Biol Chem 276: 16567-16572, 2001 10.1074/jbc.M011302200
25. Yu L, Cao G, Repa J, Stangl H: Sterol regulation of scavenger receptor class B type I in macrophages. J Lipid Res 45: 889-899, 2004 10.1194/ jlr.M300461-JLR200
26. Lam MCW, Tan KCB, Lam KSL: Glycoxidized low-density lipoprotein regulates the expression of scavenger receptors in THP-1 macrophages. Atherosclerosis 177: 313-320, 2004 10.1016/j.atherosclerosis.2004.08.003
27. Plutzky J: Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: Emerging insights for evolving paradigm. Curr Atheroscler Rep 2: 327-335, 2000 11122762
28. Collins AR, Meehan WP, Kintscher U, Jackson S, Wakino S, Noh G, Palinski W, Hsueh WA, Law RE: Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 21: 365-371, 2001 11231915
29. Argmann CA, Sawyez CG, McNeil CJ, Hegele RA, Huff WM: Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoprotein. Arterioscler Thromb Vasc Biol 23: 475-482, 2003 10.1161/01.ATV.0000058860.62870.6E
30. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM: PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252, 1998 10.1016/S0092-8674(00)81575-5
31. Malerod L, Sporstol M, Juvet LK, Mousavi A, Gjoen T, Berg T: Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor gamma and hepatocytes nuclear factor 4alpha. Bochem Biophys Res Commun 305: 557-565, 2003 10.1016/ S0006-291X(03)00819-2
32. Malerod L, Juvet LK, Hanssen-Bauer A, Eskild W, Berg T: Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochem Biophys Res Commun 299: 916-923, 2002 10.1016/S0006-291X(02)02760-2
33. Lopez D, McLean MP: Sterol regulatory element-binding protein-1a binds to cis elements in the promoter of the rat high density lipoprotein recptor SR-BI gene. Endocrinology 140: 5669-5681, 1999 10.1210/ en.140.12.5669
34. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM: PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7: 48-52, 2001 10.1038/83336